Oguri H, Suganuma N, Kikkawa F, Ishihara Y, Seo H, Matsui N, Tomoda Y
Department of Obstetrics and Gynecology, School of Medicine, Nagoya University, Japan.
Endocrinol Jpn. 1989 Jun;36(3):395-401. doi: 10.1507/endocrj1954.36.395.
We have shown that administration of estrogen which increases prolactin (PRL) synthesis in the rat may be mediated by an increase in poly [adenosine diphosphate ribose (ADP-ribose)] synthesis. Present investigation was attempted to study whether poly (ADP-ribose) synthesis is involved in rat PRL gene expression during early pregnancy. Anterior pituitaries were obtained on days 0, 2, 4, 6, 8, 10 and 12 of pregnancy (group C). Another group of pregnant rats was given nicotinamide, an inhibitor of poly (ADP-ribose) synthesis twice a day intra-peritoneally from day 0 to the day of sacrifice (group N). Serum estradiol (E2) concentration was determined by radioimmunoassay. PRL mRNA was measured by cytoplasmic dot hybridization using 32P-labeled cDNA. Poly (ADP-ribose) synthesis was assessed by incubating purified nuclei with 14C-nicotinamide adenine dinucleotide. The serum concentration of E2 increased between days 2 and 4, and on day 6 it decreased to the level of day 0. It remained low until day 12. No difference in the serum E2 level was observed in groups C and N. In group C, PRL mRNA increased from day 2 and remained high until day 8. In group C, poly (ADP-ribose) synthesis increased between days 2 and 4, decreased on day 6 to the level of day 0, and thereafter gradually increased until day 10. Administration of nicotinamide abolished the increase in poly (ADP-ribose) synthesis observed in group C during early pregnancy. In group N, the increase in PRL mRNA was completely suppressed. It is suggested that the increase in PRL mRNA in early pregnancy may be mediated by increased poly (ADP-ribose) synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)
我们已经表明,在大鼠中增加催乳素(PRL)合成的雌激素给药可能是由聚[二磷酸腺苷核糖(ADP-核糖)]合成增加介导的。目前的研究试图探讨聚(ADP-核糖)合成是否参与妊娠早期大鼠PRL基因的表达。在妊娠第0、2、4、6、8、10和12天获取垂体前叶(C组)。另一组妊娠大鼠从第0天到处死当天每天两次腹腔注射聚(ADP-核糖)合成抑制剂烟酰胺(N组)。通过放射免疫测定法测定血清雌二醇(E2)浓度。使用32P标记的cDNA通过细胞质点杂交法测量PRL mRNA。通过用14C-烟酰胺腺嘌呤二核苷酸孵育纯化的细胞核来评估聚(ADP-核糖)合成。E2的血清浓度在第2天至第4天之间升高,在第6天降至第0天的水平。直到第12天它都保持在低水平。在C组和N组中未观察到血清E2水平的差异。在C组中,PRL mRNA从第2天开始增加并一直保持高水平直到第8天。在C组中,聚(ADP-核糖)合成在第2天至第4天之间增加,在第6天降至第0天的水平,此后逐渐增加直到第10天。烟酰胺的给药消除了妊娠早期C组中观察到的聚(ADP-核糖)合成的增加。在N组中,PRL mRNA的增加被完全抑制。提示妊娠早期PRL mRNA的增加可能是由聚(ADP-核糖)合成增加介导的。(摘要截短于250字)